116 related articles for article (PubMed ID: 31599544)
1. Hemagglutinin consensus-based prophylactic approaches to overcome influenza virus diversity.
Sautto GA; Ross TM
Vet Ital; 2019 Sep; 55(3):195-201. PubMed ID: 31599544
[TBL] [Abstract][Full Text] [Related]
2. Computationally Optimized Broadly Reactive Hemagglutinin Elicits Hemagglutination Inhibition Antibodies against a Panel of H3N2 Influenza Virus Cocirculating Variants.
Wong TM; Allen JD; Bebin-Blackwell AG; Carter DM; Alefantis T; DiNapoli J; Kleanthous H; Ross TM
J Virol; 2017 Dec; 91(24):. PubMed ID: 28978710
[TBL] [Abstract][Full Text] [Related]
3. Emerging influenza viruses and the prospect of a universal influenza virus vaccine.
Krammer F
Biotechnol J; 2015 May; 10(5):690-701. PubMed ID: 25728134
[TBL] [Abstract][Full Text] [Related]
4. Towards a universal influenza vaccine: different approaches for one goal.
Sautto GA; Kirchenbaum GA; Ross TM
Virol J; 2018 Jan; 15(1):17. PubMed ID: 29370862
[TBL] [Abstract][Full Text] [Related]
5. Neuraminidase-Inhibiting Antibody Titers Correlate with Protection from Heterologous Influenza Virus Strains of the Same Neuraminidase Subtype.
Walz L; Kays SK; Zimmer G; von Messling V
J Virol; 2018 Sep; 92(17):. PubMed ID: 29925654
[TBL] [Abstract][Full Text] [Related]
6. Vaccination with Vesicular Stomatitis Virus-Vectored Chimeric Hemagglutinins Protects Mice against Divergent Influenza Virus Challenge Strains.
Ryder AB; Nachbagauer R; Buonocore L; Palese P; Krammer F; Rose JK
J Virol; 2015 Dec; 90(5):2544-50. PubMed ID: 26676789
[TBL] [Abstract][Full Text] [Related]
7. Vaccination with Recombinant Parainfluenza Virus 5 Expressing Neuraminidase Protects against Homologous and Heterologous Influenza Virus Challenge.
Mooney AJ; Gabbard JD; Li Z; Dlugolenski DA; Johnson SK; Tripp RA; He B; Tompkins SM
J Virol; 2017 Dec; 91(23):. PubMed ID: 28931689
[TBL] [Abstract][Full Text] [Related]
8. A Bivalent Heterologous DNA Virus-Like-Particle Prime-Boost Vaccine Elicits Broad Protection against both Group 1 and 2 Influenza A Viruses.
Jiang W; Wang S; Chen H; Ren H; Huang X; Wang G; Chen Z; Chen L; Chen Z; Zhou P
J Virol; 2017 May; 91(9):. PubMed ID: 28179535
[TBL] [Abstract][Full Text] [Related]
9. Mosaic H5 Hemagglutinin Provides Broad Humoral and Cellular Immune Responses against Influenza Viruses.
Kamlangdee A; Kingstad-Bakke B; Osorio JE
J Virol; 2016 Aug; 90(15):6771-6783. PubMed ID: 27194759
[TBL] [Abstract][Full Text] [Related]
10. Prospects for antibody-based universal influenza vaccines in the context of widespread pre-existing immunity.
Wheatley AK; Kent SJ
Expert Rev Vaccines; 2015; 14(9):1227-39. PubMed ID: 26175180
[TBL] [Abstract][Full Text] [Related]
11. Development of a Pan-H1 Influenza Vaccine.
Darricarrère N; Pougatcheva S; Duan X; Rudicell RS; Chou TH; DiNapoli J; Ross TM; Alefantis T; Vogel TU; Kleanthous H; Wei CJ; Nabel GJ
J Virol; 2018 Nov; 92(22):. PubMed ID: 30185594
[TBL] [Abstract][Full Text] [Related]
12. Universal influenza vaccines: Shifting to better vaccines.
Berlanda Scorza F; Tsvetnitsky V; Donnelly JJ
Vaccine; 2016 Jun; 34(26):2926-2933. PubMed ID: 27038130
[TBL] [Abstract][Full Text] [Related]
13. Chimeric Hemagglutinin Constructs Induce Broad Protection against Influenza B Virus Challenge in the Mouse Model.
Ermler ME; Kirkpatrick E; Sun W; Hai R; Amanat F; Chromikova V; Palese P; Krammer F
J Virol; 2017 Jun; 91(12):. PubMed ID: 28356526
[TBL] [Abstract][Full Text] [Related]
14. Vaccine approaches conferring cross-protection against influenza viruses.
Vemula SV; Sayedahmed EE; Sambhara S; Mittal SK
Expert Rev Vaccines; 2017 Nov; 16(11):1141-1154. PubMed ID: 28925296
[TBL] [Abstract][Full Text] [Related]
15. Next generation live-attenuated influenza vaccine platforms.
Ullah S; Ross TM
Expert Rev Vaccines; 2022 Aug; 21(8):1097-1110. PubMed ID: 35502639
[TBL] [Abstract][Full Text] [Related]
16. Influenza virus-like particle can accommodate multiple subtypes of hemagglutinin and protect from multiple influenza types and subtypes.
Pushko P; Pearce MB; Ahmad A; Tretyakova I; Smith G; Belser JA; Tumpey TM
Vaccine; 2011 Aug; 29(35):5911-8. PubMed ID: 21723354
[TBL] [Abstract][Full Text] [Related]
17. Elicitation of Broadly Protective Antibodies following Infection with Influenza Viruses Expressing H1N1 Computationally Optimized Broadly Reactive Hemagglutinin Antigens.
Sautto GA; Kirchenbaum GA; Ecker JW; Bebin-Blackwell AG; Pierce SR; Ross TM
Immunohorizons; 2018 Aug; 2(7):226-237. PubMed ID: 31022693
[TBL] [Abstract][Full Text] [Related]
18. Influenza Vaccines: Successes and Continuing Challenges.
Becker T; Elbahesh H; Reperant LA; Rimmelzwaan GF; Osterhaus ADME
J Infect Dis; 2021 Sep; 224(12 Suppl 2):S405-S419. PubMed ID: 34590139
[TBL] [Abstract][Full Text] [Related]
19. Universal influenza vaccines, science fiction or soon reality?
de Vries RD; Altenburg AF; Rimmelzwaan GF
Expert Rev Vaccines; 2015; 14(10):1299-301. PubMed ID: 26104835
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of live attenuated influenza vaccine in children against influenza B viruses by lineage and antigenic similarity.
Belshe RB; Coelingh K; Ambrose CS; Woo JC; Wu X
Vaccine; 2010 Feb; 28(9):2149-56. PubMed ID: 20003926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
